Good news! Sailu Medical has been recognized as a Shenzhen-based specialized and innovative enterprise

Shenzhen Sailu Medical Technology Co., Ltd. (hereinafter referred to as Sailu Medical or the Company) was established in October 2020. It is mainly engaged in the research and development and production of cutting-edge equipment such as internationally leading genetic testing instruments and spatial omics platforms. The company has broken through the bottlenecks of previous sequencing products in terms of throughput, cost, resolution, automation, etc., breaking the foreign monopoly, and realizing full localization based on independent intellectual property rights, reaching the world's leading level. At the same time, it has built the world's first super-resolution spatial omics platform to provide comprehensive solutions for clinical and scientific research applications. The company has passed the EU CE-IVDR certification and obtained sales qualifications in markets such as Europe, the Middle East, and other Asian countries, and its products are sold at home and abroad.

Mainly engaged in the research and development and production of cutting-edge equipment such as internationally leading genetic testing instruments and spatial omics platforms. The company has broken through the bottlenecks of previous sequencing products in terms of throughput, cost, resolution, automation, etc., breaking the foreign monopoly, realizing full localization based on independent intellectual property rights, reaching the world's leading level. At the same time, it has built the world's first super-resolution spatial omics platform to provide comprehensive solutions for clinical and scientific research applications. The company has passed the EU CE-IVDR certification and obtained sales qualifications in markets such as Europe, the Middle East, and other Asian countries, and its products are sold at home and abroad.

The company has broken through the bottlenecks of previous sequencing products in terms of throughput, cost, resolution, and automation, breaking the foreign monopoly, and achieving full localization based on independent intellectual property rights, reaching the world's leading level. At the same time, it has built the world's first super-resolution spatial omics platform to provide comprehensive solutions for clinical and scientific research applications. The company has passed the EU CE-IVDR certification and obtained sales qualifications in markets such as Europe, the Middle East, and other Asian countries, and its products are sold at home and abroad.